nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

08.09.2023 | Research

Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma

verfasst von: Huifang Zuo, Min-Min Li

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 17/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

A nomogram is a valuable and easily accessible tool for individualizing cancer prognosis. This study aims to establish and validate two prognostic nomograms for long-term overall survival (OS) and cancer‐specific survival (CSS) in non-metastatic nasopharyngeal carcinoma (NPC) patients and to investigate the treatment options for the nomogram-based risk stratification subgroups.

Methods

A total of 3959 patients with non-metastatic NPC between 2004 and 2015 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. The patients were randomly allocated to the training and validation cohorts in a 7:3 ratio. Prognostic nomograms were constructed to estimate OS and CSS by integrating significant variables from multivariate Cox regression employing a backward stepwise method. We examined the correlation indices (C-index) and areas under the curves (AUC) of time-dependent receiver operating characteristic curves to assess the discriminative ability of our survival models. The comprehensive enhancements of predictive performance were evaluated with net reclassification operating improvement (NRI) and integrated discrimination improvement (IDI). Reliability was validated using calibration plots. Decision curve analysis (DCA) was used to estimate clinical efficacy and capability. Finally, the nomogram-based risk stratification system used Kaplan–Meier survival analysis and log-rank tests to examine differences between subgroups.

Results

The following independent parameters were significant predictors for OS: sex, age, race, marital status, histological type, median household income, AJCC stage tumor size, and lymph node size. Except for the race variables mentioned above, the rest were independent prognostic factors for CSS. The C-index, AUC, NRI, and IDI indicated satisfactory discriminating properties. The calibration curves exhibited high concordance with the exact outcomes. Moreover, the DCA demonstrated performed well for net benefits. The prognosis significantly differed between low- and high-risk patients (p < 0.001). In a treatment-based stratified survival analysis in risk-stratified subgroups, chemotherapy benefited patients in the high-risk group compared to radiotherapy alone. Radiotherapy only was recommended in the low-risk group.

Conclusions

Our nomograms have satisfactory performance and have been validated. It can assist clinicians in prognosis assessment and individualized treatment of non-metastatic NPC patients.

Aizer AA, Chen M-H, McCarthy EP et al (2013) Marital status and survival in patients with cancer. J Clin Oncol 31:3869–3876. https://doi.org/10.1200/JCO.2013.49.6489CrossRefPubMedPubMedCentral

Brody-Camp S, McCoul ED, Lefante JJ, Aslam R (2021) Socioeconomic status and survival in nasopharyngeal carcinoma: a population-based study. Laryngoscope 131:2719–2723. https://doi.org/10.1002/lary.29702CrossRefPubMed

Chen C, Fei Z, Pan J et al (2011) Significance of primary tumor volume and T-stage on prognosis in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Jpn J Clin Oncol 41:537–542. https://doi.org/10.1093/jjco/hyq242CrossRefPubMed

Chen L, Zhang Y, Lai S-Z et al (2019) 10-year results of therapeutic ratio by intensity-modulated radiotherapy versus two-dimensional radiotherapy in patients with nasopharyngeal carcinoma. Oncologist 24:e38–e45. https://doi.org/10.1634/theoncologist.2017-0577CrossRefPubMed

Chen Z-H, Yang K-B, Zhang Y et al (2021) Assessment of modifiable factors for the association of marital status with cancer-specific survival. JAMA Netw Open 4:e2111813. https://doi.org/10.1001/jamanetworkopen.2021.11813CrossRefPubMedPubMedCentral

Cheung F, Chan O, Ng WT et al (2012) The prognostic value of histological typing in nasopharyngeal carcinoma. Oral Oncol 48:429–433. https://doi.org/10.1016/j.oraloncology.2011.11.017CrossRefPubMed

Cho J-K, Lee G-J, Yi K-I et al (2015) Development and external validation of nomograms predictive of response to radiation therapy and overall survival in nasopharyngeal cancer patients. Eur J Cancer 51:1303–1311. https://doi.org/10.1016/j.ejca.2015.04.003CrossRefPubMed

Chua MLK, Wee JTS, Hui EP, Chan ATC (2016) Nasopharyngeal carcinoma. Lancet 387:1012–1024. https://doi.org/10.1016/S0140-6736(15)00055-0CrossRefPubMed

Ford JL, Stowe RP (2013) Racial-ethnic differences in Epstein-Barr virus antibody titers among U.S. children and adolescents. Ann Epidemiol 23:275–280. https://doi.org/10.1016/j.annepidem.2013.02.008CrossRefPubMed

Guo R, Wu H, Wang J et al (2019) Lymph node status and outcomes for nasopharyngeal carcinoma according to histological subtypes: a SEER population-based retrospective analysis. Adv Ther 36:3123–3133. https://doi.org/10.1007/s12325-019-01100-7CrossRefPubMed

Hilden J, Gerds TA (2014) A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index. Stat Med 33:3405–3414. https://doi.org/10.1002/sim.5804CrossRefPubMed

Houen G, Trier NH (2020) Epstein-Barr virus and systemic autoimmune diseases. Front Immunol 11:587380. https://doi.org/10.3389/fimmu.2020.587380CrossRefPubMed

Huang S-J, Tang Y-Y, Liu H-M et al (2018a) Impact of age on survival of locoregional nasopharyngeal carcinoma: an analysis of the Surveillance, Epidemiology, and End Results program database, 2004–2013. Clin Otolaryngol 43:1209–1218. https://doi.org/10.1111/coa.13124CrossRefPubMed

Huang X-D, Zhou G-Q, Lv J-W et al (2018b) Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data, intelligence platform-based analysis. Radiother Oncol 129:389–395. https://doi.org/10.1016/j.radonc.2018.09.004CrossRefPubMed

Huang C-L, Chen Y, Guo R et al (2020) Prognostic value of MRI-determined cervical lymph node size in nasopharyngeal carcinoma. Cancer Med 9:7100–7106. https://doi.org/10.1002/cam4.3392CrossRefPubMedPubMedCentral

Jalbout M, Bel Hadj Jrad B, Bouaouina N et al (2002) Autoantibodies to tubulin are specifically associated with the young age onset of nasopharyngeal carcinoma. Int J Cancer 101:146–150. https://doi.org/10.1002/ijc.10586CrossRefPubMed

Johnson S, McDonald JT, Corsten MJ (2008) Socioeconomic factors in head and neck cancer. J Otolaryngol Head Neck Surg 37:597–601PubMed

Lee AWM, Ng WT, Chan JYW et al (2019a) Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev 79:101890. https://doi.org/10.1016/j.ctrv.2019.101890CrossRefPubMed

Lee HM, Okuda KS, González FE, Patel V (2019b) Current perspectives on nasopharyngeal carcinoma. In: Rhim JS, Dritschilo A, Kremer R (eds) Human cell transformation: advances in cell models for the study of cancer and aging. Springer International Publishing, Cham, pp 11–34CrossRef

Lu Y, Hua J, Yan F et al (2021) Combined radiotherapy and chemotherapy versus radiotherapy alone in elderly patients with nasopharyngeal carcinoma. Medicine (baltimore) 100:e26629. https://doi.org/10.1097/MD.0000000000026629CrossRefPubMed

Ma BBY, Poon TCW, To KF et al (2003) Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma? A prospective study. Head Neck 25:864–872. https://doi.org/10.1002/hed.10307CrossRefPubMed

Mao Y-P, Tang L-L, Chen L et al (2016) Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy. Chin J Cancer 35:103. https://doi.org/10.1186/s40880-016-0167-2CrossRefPubMedPubMedCentral

Moulla Y, Lyros O, Adolf D et al (2018) A nomogram based on clinical factors to predict the serum myoglobin levels following bariatric surgery. Obes Surg 28:1697–1703. https://doi.org/10.1007/s11695-017-3078-7CrossRefPubMed

Müller von der Grün J, Martin D, Stöver T et al (2018) Chemoradiotherapy as definitive treatment for elderly patients with head and neck cancer. Biomed Res Int 2018:3508795. https://doi.org/10.1155/2018/3508795CrossRefPubMedPubMedCentral

Ng WT, Yuen KT, Au KH et al (2014) Staging of nasopharyngeal carcinoma: the past, the present and the future. Oral Oncol 50:549–554. https://doi.org/10.1016/j.oraloncology.2013.06.003CrossRefPubMed

Ou S-HI, Zell JA, Ziogas A, Anton-Culver H (2007) Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol 18:29–35. https://doi.org/10.1093/annonc/mdl320CrossRefPubMed

Pagedar NA, Davis AB, Sperry SM et al (2019) Population analysis of socioeconomic status and otolaryngologist distribution on head and neck cancer outcomes. Head Neck 41:1046–1052. https://doi.org/10.1002/hed.25521CrossRefPubMed

Pan Z, You H, Bu Q et al (2019) Development and validation of a nomogram for predicting cancer-specific survival in patients with Wilms’ tumor. J Cancer 10:5299–5305. https://doi.org/10.7150/jca.32741CrossRefPubMedPubMedCentral

Pan X-X, Liu Y-J, Yang W et al (2020) Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients. Laryngoscope 130:E83–E88. https://doi.org/10.1002/lary.28099CrossRefPubMed

Reddy SP, Raslan WF, Gooneratne S et al (1995) Prognostic significance of keratinization in nasopharyngeal carcinoma. Am J Otolaryngol 16:103–108. https://doi.org/10.1016/0196-0709(95)90040-3CrossRefPubMed

Ren Y, Qiu H, Yuan Y et al (2017) Evaluation of 7th edition of AJCC staging system for nasopharyngeal carcinoma. J Cancer 8:1665–1672. https://doi.org/10.7150/jca.19197CrossRefPubMedPubMedCentral

Rendall MS, Weden MM, Favreault MM, Waldron H (2011) The protective effect of marriage for survival: a review and update. Demography 48:481–506. https://doi.org/10.1007/s13524-011-0032-5CrossRefPubMed

Richey LM, Olshan AF, George J et al (2006) Incidence and survival rates for young blacks with nasopharyngeal carcinoma in the United States. Arch Otolaryngol-Head Neck Surg 132:1035–1040. https://doi.org/10.1001/archotol.132.10.1035CrossRefPubMed

Roy Chattopadhyay N, Das P, Chatterjee K, Choudhuri T (2017) Higher incidence of nasopharyngeal carcinoma in some regions in the world confers for interplay between genetic factors and external stimuli. Drug Discov Ther 11:170–180. https://doi.org/10.5582/ddt.2017.01030CrossRefPubMed

Sham JS, Choy D, Wei WI (1990) Nasopharyngeal carcinoma: orderly neck node spread. Int J Radiat Oncol Biol Phys 19:929–933. https://doi.org/10.1016/0360-3016(90)90014-bCrossRefPubMed

Sinha S, Gajra A (2022) Nasopharyngeal cancer. StatPearls Publishing

Song W, Lv C-G, Miao D-L et al (2018) Development and validation of a nomogram for predicting survival in patients with gastrointestinal stromal tumours. Eur J Surg Oncol 44:1657–1665. https://doi.org/10.1016/j.ejso.2018.07.004CrossRefPubMed

Sun X, Su S, Chen C et al (2014) Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol 110:398–403. https://doi.org/10.1016/j.radonc.2013.10.020CrossRefPubMed

Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660CrossRef

Talluri R, Shete S (2016) Using the weighted area under the net benefit curve for decision curve analysis. BMC Med Inform Decis Mak 16:94. https://doi.org/10.1186/s12911-016-0336-xCrossRefPubMedPubMedCentral

Tang L-L, Chen W-Q, Xue W-Q et al (2016) Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett 374:22–30. https://doi.org/10.1016/j.canlet.2016.01.040CrossRefPubMed

Tsao SW, Tsang CM, Lo KW (2017) Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond B 372:20160270. https://doi.org/10.1098/rstb.2016.0270CrossRef

Van Calster B, Vickers AJ (2015) Calibration of risk prediction models: impact on decision-analytic performance. Med Decis Mak 35:162–169. https://doi.org/10.1177/0272989X14547233CrossRef

Vazquez A, Khan MN, Govindaraj S et al (2014) Nasopharyngeal squamous cell carcinoma: a comparative analysis of keratinizing and nonkeratinizing subtypes. Int Forum Allergy Rhinol 4:675–683. https://doi.org/10.1002/alr.21332CrossRefPubMed

Vickers AJ, Elkin EB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Mak 26:565–574. https://doi.org/10.1177/0272989X06295361CrossRef

Wang Y, Zhang Y, Ma S (2013) Racial differences in nasopharyngeal carcinoma in the United States. Cancer Epidemiol. https://doi.org/10.1016/j.canep.2013.08.008CrossRefPubMedPubMedCentral

Wei WI, Sham JST (2005) Nasopharyngeal carcinoma. Lancet 365:2041–2054. https://doi.org/10.1016/S0140-6736(05)66698-6CrossRefPubMed

Wu S-G, Lian C-L, Wang J et al (2019) The effect of histological subtypes on survival outcome in nasopharyngeal carcinoma after extensive follow up. Ann Transl Med 7:768–768. https://doi.org/10.21037/atm.2019.11.75CrossRefPubMedPubMedCentral

Wu W-T, Li Y-J, Feng A-Z et al (2021) Data mining in clinical big data: the frequently used databases, steps, and methodological models. Mil Med Res 8:44. https://doi.org/10.1186/s40779-021-00338-zCrossRefPubMedPubMedCentral

Yang L, Hong S, Wang Y et al (2015) Development and external validation of nomograms for predicting survival in nasopharyngeal carcinoma patients after definitive radiotherapy. Sci Rep. https://doi.org/10.1038/srep15638CrossRefPubMedPubMedCentral

Yang J, Li Y, Liu Q et al (2020) Brief introduction of medical database and data mining technology in big data era. J Evid Based Med 13:57–69. https://doi.org/10.1111/jebm.12373CrossRefPubMedPubMedCentral

Zhang Q-X, Zhuang L-P, Lin Z-Y (2021) Prognostic models for 1-year survival of NPC after radiotherapy in different ages. Eur Arch Otorhinolaryngol 278:4955–4965. https://doi.org/10.1007/s00405-021-06730-8CrossRefPubMed

Titel: Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma
verfasst von: Huifang Zuo
Min-Min Li
Publikationsdatum: 08.09.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 17/2023
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-023-05363-0

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma

Abstract

Background

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 17/2023

Serum THBS2 is a potential biomarker for the diagnosis of non-small cell lung cancer

Predicting the prognosis of operable gastric cancer patients by dynamic changes in platelets before and after surgery: a retrospective cohort study

Treatment patterns in stage III non‑small‑cell lung cancer patients: a population‑based study using German cancer registry data

STAT1 suppresses the transcriptional activity of TRIM21 in gastric cancer

Deciphering the implications of mitophagy-related signatures in clinical outcomes and microenvironment heterogeneity of clear cell renal cell carcinoma

Machine learning and single-cell sequencing reveal the potential regulatory factors of mitochondrial autophagy in the progression of gastric cancer

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie